-
1
-
-
0011802140
-
Biochemical (PSA): Recurrence probability following radical retropubic prostatectomy for clinically localized prostate cancer
-
abstr 610
-
Han M, Lai S, Partin AW, et al: Biochemical (PSA): Recurrence probability following radical retropubic prostatectomy for clinically localized prostate cancer. J Urol 165:149, 2001 (abstr 610)
-
(2001)
J Urol
, vol.165
, pp. 149
-
-
Han, M.1
Lai, S.2
Partin, A.W.3
-
2
-
-
0033526343
-
Radiation therapy for clinically localized prostate cancer: A multi-institutional pooled analysis
-
Shipley WU, Thames HD, Sandler HM, et al: Radiation therapy for clinically localized prostate cancer: A multi-institutional pooled analysis. JAMA 281:1598-1604, 1999
-
(1999)
JAMA
, vol.281
, pp. 1598-1604
-
-
Shipley, W.U.1
Thames, H.D.2
Sandler, H.M.3
-
3
-
-
0032538069
-
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer
-
D'Amico AV, Whittington R, Malkowicz SB, et al: Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:969-974, 1998
-
(1998)
JAMA
, vol.280
, pp. 969-974
-
-
D'Amico, A.V.1
Whittington, R.2
Malkowicz, S.B.3
-
4
-
-
0032550753
-
A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer
-
Kattan MW, Easthan JA, Stapleton AMF, et al: A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 90:766-771, 1998
-
(1998)
J Natl Cancer Inst
, vol.90
, pp. 766-771
-
-
Kattan, M.W.1
Easthan, J.A.2
Stapleton, A.M.F.3
-
5
-
-
0032537993
-
Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer
-
Albertsen PC, Hanley JA, Gleason DF, et al: Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 280:975-980, 1998
-
(1998)
JAMA
, vol.280
, pp. 975-980
-
-
Albertsen, P.C.1
Hanley, J.A.2
Gleason, D.F.3
-
6
-
-
0033526309
-
Natural history of progression after PSA elevation following radical prostatectomy
-
Pound CR, Partin AW, Eisenberger MA, et al: Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281:1591-1597, 1999
-
(1999)
JAMA
, vol.281
, pp. 1591-1597
-
-
Pound, C.R.1
Partin, A.W.2
Eisenberger, M.A.3
-
7
-
-
0031014008
-
Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: Clinical observations
-
Lee WR, Hanks GE, Hanlon A: Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: Clinical observations. J Clin Oncol 15:230-238, 1997
-
(1997)
J Clin Oncol
, vol.15
, pp. 230-238
-
-
Lee, W.R.1
Hanks, G.E.2
Hanlon, A.3
-
8
-
-
0001916430
-
Histologic grading and staging of prostatic carcinoma
-
Philadelphia, PA, Lea & Febiger
-
Gleason DF and the Veterans Administration Cooperative Urological Research Group: Histologic grading and staging of prostatic carcinoma, in Tannenbaum M (ed): Urologic Pathology. Philadelphia, PA, Lea & Febiger, 1977, pp 171-187
-
(1977)
Urologic Pathology
, pp. 171-187
-
-
Gleason, D.F.1
-
9
-
-
0030887860
-
Using prostate-specific antigen to eliminate the staging radionuclide bone scan
-
Lee CT, Oesterling JE: Using prostate-specific antigen to eliminate the staging radionuclide bone scan. Urol Clin North Am 24:389-394, 1997
-
(1997)
Urol Clin North Am
, vol.24
, pp. 389-394
-
-
Lee, C.T.1
Oesterling, J.E.2
-
10
-
-
0003452668
-
-
Philadelphia, PA, Lippincott
-
Beahrs OH, Henson DE, Hutter RVP: American Joint Committee on Cancer, Manual for Staging of Cancer (ed 4). Philadelphia, PA, Lippincott, 1992
-
(1992)
Manual for Staging of Cancer (Ed 4)
-
-
Beahrs, O.H.1
Henson, D.E.2
Hutter, R.V.P.3
-
11
-
-
0033026308
-
Comparison of radiation side effects of conformal and conventional radiotherapy in prostate cancer: A randomized trial
-
Dearnaley D, Khoo V, Norman A, et al: Comparison of radiation side effects of conformal and conventional radiotherapy in prostate cancer: A randomized trial. Lancet 353:267-272, 1999
-
(1999)
Lancet
, vol.353
, pp. 267-272
-
-
Dearnaley, D.1
Khoo, V.2
Norman, A.3
-
12
-
-
0030906817
-
Consensus statement: Guidelines for PSA following radiation therapy
-
Cox JD, for the American Society for Therapeutic Radiology and Oncology Consensus Panel: Consensus statement: Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 37:1035-1041, 1997
-
(1997)
Int J Radiat Oncol Biol Phys
, vol.37
, pp. 1035-1041
-
-
Cox, J.D.1
-
13
-
-
0002595781
-
Simultaneous inferences and other topic in regression analysis-1
-
Homewood, IL, Richard D. Irwin, Inc
-
Neter J, Wasserman W, Kutner M (eds): Simultaneous inferences and other topic in regression analysis-1, in Applied Linear Regression Models. Homewood, IL, Richard D. Irwin, Inc, 1983, pp 150-153
-
(1983)
Applied Linear Regression Models
, pp. 150-153
-
-
Neter, J.1
Wasserman, W.2
Kutner, M.3
-
14
-
-
0034307224
-
Overall survival after prostate-specific-antigen-detected recurrence following conformal radiation therapy
-
Sandler HM, Dunn RL, McLaughlin PW, et al: Overall survival after prostate-specific-antigen-detected recurrence following conformal radiation therapy. Int J Radiat Oncol Biol Phys 48:629-633, 2000
-
(2000)
Int J Radiat Oncol Biol Phys
, vol.48
, pp. 629-633
-
-
Sandler, H.M.1
Dunn, R.L.2
McLaughlin, P.W.3
-
15
-
-
33845382806
-
Nonparametric estimation from incomplete observations
-
Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
-
(1958)
J Am Stat Assoc
, vol.53
, pp. 457-481
-
-
Kaplan, E.L.1
Meier, P.2
-
16
-
-
21144484803
-
On the use of cause-specific failure and conditional failure probabilities: Examples from clinical oncology data
-
Gaynor JJ, Feur FJ, Tan CC, et al: On the use of cause-specific failure and conditional failure probabilities: Examples from clinical oncology data. J Am Stat Assoc 88:400-409, 1993
-
(1993)
J Am Stat Assoc
, vol.88
, pp. 400-409
-
-
Gaynor, J.J.1
Feur, F.J.2
Tan, C.C.3
-
17
-
-
0032950295
-
Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer
-
Kattan MW, Wheeler TM, Scardino PT: Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 17:1499-1507, 1999
-
(1999)
J Clin Oncol
, vol.17
, pp. 1499-1507
-
-
Kattan, M.W.1
Wheeler, T.M.2
Scardino, P.T.3
-
18
-
-
0034666335
-
Utilizing predictions of early prostate-specific antigen failure to optimize patient selection for adjuvant therapy trials
-
D'Amico AV, Whittington R, Malkowicz SB, et al: Utilizing predictions of early prostate-specific antigen failure to optimize patient selection for adjuvant therapy trials. J Clin Oncol 18:3240-3246, 2000
-
(2000)
J Clin Oncol
, vol.18
, pp. 3240-3246
-
-
D'Amico, A.V.1
Whittington, R.2
Malkowicz, S.B.3
-
19
-
-
0030856678
-
Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin
-
Bolla M, Gonsalez D, Warde P, et al: Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 337:295-300, 1997
-
(1997)
N Engl J Med
, vol.337
, pp. 295-300
-
-
Bolla, M.1
Gonsalez, D.2
Warde, P.3
-
20
-
-
0030815150
-
Recurrence patterns after radical retropubic prostatectomy: Clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen
-
Patel A, Dorey F, Franklin J, et al: Recurrence patterns after radical retropubic prostatectomy: Clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen. J Urol 158:1441-1445, 1997
-
(1997)
J Urol
, vol.158
, pp. 1441-1445
-
-
Patel, A.1
Dorey, F.2
Franklin, J.3
-
21
-
-
0035003725
-
PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer
-
Roberts SG, Blute ML, Bergstralh EJ, et al: PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer. Mayo Clin Proc 76:576-581, 2001
-
(2001)
Mayo Clin Proc
, vol.76
, pp. 576-581
-
-
Roberts, S.G.1
Blute, M.L.2
Bergstralh, E.J.3
-
22
-
-
0030857412
-
Rate of PSA rise predicts metastatic versus local recurrence after definitive radiotherapy
-
Sartor CI, Strawderman MH, Lin XH, et al: Rate of PSA rise predicts metastatic versus local recurrence after definitive radiotherapy. Int J Radiat Oncol Biol Phys 38:941-947, 1997
-
(1997)
Int J Radiat Oncol Biol Phys
, vol.38
, pp. 941-947
-
-
Sartor, C.I.1
Strawderman, M.H.2
Lin, X.H.3
-
23
-
-
0031403675
-
Immediate versus deferred treatment for advanced prostatic cancer: Initial results of the Medical Research Council Trial - The Medical Research Council Prostate Cancer Working Party Investigators Group
-
Immediate versus deferred treatment for advanced prostatic cancer: Initial results of the Medical Research Council Trial - The Medical Research Council Prostate Cancer Working Party Investigators Group. Br J Urol 79:235-246, 1997
-
(1997)
Br J Urol
, vol.79
, pp. 235-246
-
-
-
24
-
-
0033540004
-
Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer
-
Messing EM, Manola J, Sarosdy M, et al: Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med 341:1781-1788, 1999
-
(1999)
N Engl J Med
, vol.341
, pp. 1781-1788
-
-
Messing, E.M.1
Manola, J.2
Sarosdy, M.3
-
25
-
-
0024520844
-
Surrogate endpoints in clinical trials: Definition and operational criteria
-
Prentice RL: Surrogate endpoints in clinical trials: Definition and operational criteria. Stat Med 8:431-440, 1989
-
(1989)
Stat Med
, vol.8
, pp. 431-440
-
-
Prentice, R.L.1
|